AKTX - CIK 0001541157
Akari Therapeutics Plc has filed 710 documents with the SEC between 2012 and 2026. The most frequent type is 6-k (188 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Securities registration | S-3 | 2024-09-06 | - |
| Major company event | 8-K | 2024-09-06 | 2024-09-06 |
| Major company event (amended) | 8-K/A | 2024-08-23 | 2024-04-25 |
| Quarterly report | 10-Q | 2024-08-19 | 2024-06-30 |
| Major company event | 8-K | 2024-08-19 | 2024-08-19 |
| NT 10-Q | - | 2024-08-15 | 2024-06-30 |
| Insider trade | 4 | 2024-07-02 | 2024-06-30 |
| Insider trade | 4 | 2024-07-02 | 2024-06-28 |
| Insider trade | 4 | 2024-07-02 | 2024-06-28 |
| Insider trade | 4 | 2024-07-02 | 2024-06-28 |
| Insider trade | 4 | 2024-07-02 | 2024-06-28 |
| Major company event | 8-K | 2024-07-01 | 2024-06-28 |
| Activist ownership stake (update) | SC 13D/A | 2024-06-20 | - |
| Activist ownership stake | SC 13D | 2024-06-18 | - |
| Activist ownership stake | SC 13D | 2024-06-07 | - |
| Major company event | 8-K | 2024-06-05 | 2024-05-31 |
| Annual report to shareholders | ARS | 2024-06-04 | 2023-12-31 |
| Insider trade | 4 | 2024-06-04 | 2024-05-31 |
| Insider trade | 4 | 2024-06-04 | 2024-05-31 |
| 425 | - | 2024-06-04 | - |
| Major company event | 8-K | 2024-06-04 | 2024-05-29 |
| Proxy statement | DEF 14A | 2024-06-03 | 2024-06-27 |
| Major company event | 8-K | 2024-05-16 | 2024-05-16 |
| Quarterly report | 10-Q | 2024-05-15 | 2024-03-31 |
| Major company event | 8-K | 2024-05-07 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| 425 | - | 2024-05-01 | - |
| Major company event | 8-K | 2024-05-01 | 2024-04-25 |
| Insider trade | 4 | 2024-04-30 | 2024-04-26 |
| Major company event | 8-K | 2024-04-11 | 2024-04-05 |
| Major company event | 8-K | 2024-04-01 | 2024-04-01 |
| Annual report | 10-K | 2024-03-29 | 2023-12-31 |
| 425 | - | 2024-03-11 | - |
| Major company event | 8-K | 2024-03-11 | 2024-03-11 |
| 425 | - | 2024-03-05 | - |
| 425 | - | 2024-03-05 | - |
| Major company event | 8-K | 2024-03-05 | 2024-03-04 |
| D | - | 2024-01-09 | - |
| Activist ownership stake (update) | SC 13D/A | 2024-01-04 | - |
| Major company event | 8-K | 2024-01-02 | 2023-12-27 |
| New insider ownership | 3 | 2024-01-02 | 2024-01-01 |
| New insider ownership | 3 | 2024-01-02 | 2024-01-01 |
| New insider ownership | 3 | 2024-01-02 | 2024-01-01 |
| New insider ownership | 3 | 2024-01-02 | 2024-01-01 |
| New insider ownership | 3 | 2024-01-02 | 2024-01-01 |
| New insider ownership | 3 | 2024-01-02 | 2024-01-01 |
| New insider ownership | 3 | 2024-01-02 | 2024-01-01 |
| 6-K | - | 2023-12-01 | 2023-12-01 |
| 6-K | - | 2023-11-16 | 2023-11-16 |
| 424B3 | - | 2023-10-27 | - |